Command Palette

Search for a command to run...

Clinical Trials · NCT01508949

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
35
Start date
Jun 2001
Locations
1 site, Denmark
Primary endpoint
Change in weight
View Liraglutide compound reference